CLINICAL TRIALS IN EUROPE
STATUS OF CLINICAL TRIALS
Max Planck Institute and Free University of Berlin (Germany) and University of Copenhagen (Denmark)
Effective and affordable treatments are needed for COVID-19 patients. We report the in vitro efficacy of Artemisia annua extracts as well as artemisinin, artesunate and artemether against CoV-2-SARS. The last two are approved active pharmaceutical ingredients for antimalarial drugs. (...) Clinical studies are needed to better assess the usefulness of these compounds as a treatment for COVID-19.
https://www.biorxiv.org/content/10.1101/2020.10.05.326637v1 (pre-publication, October 5, 2020)